DashboardAll companies
Run this on your own research
Healthcare · Drug Manufacturers - General

Johnson & Johnson

JNJNYSE$263.81−$3.80 (−1.42%)Market closed

Price Chart

Daily

Key facts

Market Cap
$635.31B
P/E
23.7x
P/B
7.79x
ROE
35.0%

Johnson & Johnson

Healthcare · Drug Manufacturers - General · FY 2025

Johnson & Johnson is a multinational corporation engaged in the research, development, production, and sale of a broad range of healthcare products. Primarily known for its pharmaceuticals, medical devices, and consumer health products, Johnson & Johnson has a significant presence in the global healthcare industry. It develops medications for a variety of fields such as immunology, oncology, neurology, infectious diseases, and vaccines. The company also produces a wide array of medical devices for surgery, orthopedics, and cardiovascular health. In addition to pharmaceuticals, Johnson & Johnson is renowned for its consumer health products, including baby care, skin and hair care, wound care, and over-the-counter pharmaceuticals, with well-recognized brands like Band-Aid, Tylenol, and Neutrogena. Operating globally, the corporation's extensive portfolio and commitment to healthcare innovation make it a pivotal player in the industry, ensuring it remains influential in addressing worldwide health challenges and advancing medical technology.

CEO
Mr. Joaquin Duato
Employees
138,100
Website
jnj.com

Company Statistics

Valuation

P/E
23.7x
P/B
7.79x
P/S
6.74x
EV/EBITDA
18.9x
P/FCF
32.9x

Margins

Gross
67.9%
EBITDA
37.3%
Operating
27.2%
Pre-Tax
34.6%
Net
28.5%

Returns

ROA
14.1%
ROE
35.0%
ROIC
17.7%

Growth (CAGR)

Rev 3Yr
5.6%
Rev 5Yr
2.7%
Op Inc 3Yr
4.8%
Net Inc 3Yr
14.3%

Financial Health

Cash & Cash Equivalents
$19.71B
Net Debt
$97.96B
Debt/Equity
144.3%
Interest Cov
—

Profile

Revenue
$94.19B
Shares Out
—
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
Johnson & Johnson (JNJ) Stock Forecast 2026 $263.81 — Price, Financials & Analyst Targets | AlphaLenz